Our Level 7 laboratories in Melbourne, Australia, recently achieved @my_green_lab certification at the Silver level – joining more than 3,000 laboratories globally working to build a culture of sustainability in science. The CSL Melbourne laboratory Green Team made practical changes to reduce environmental impact across day-to-day lab operations, including improved freezer management, reducing unnecessary energy use and training on sustainable lab practices. #MyGreenLab #Sustainability #CSL
About us
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
- Website
-
https://www.csl.com/
External link for CSL
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Melbourne, Victoria
- Type
- Public Company
- Specialties
- Complex biologicals, vaccines, plasma and plasma derived therapeutics, biotechnology, and biopharma
Employees at CSL
Locations
-
Primary
Get directions
655 Elizabeth St
Melbourne, Victoria 3000, AU
-
Get directions
1020 1st Ave
King of Prussia, PA 19406, US
Updates
-
Today we're sharing our 2026 Annual Report. We've taken important steps to strengthen CSL, improve performance and build a stronger foundation for sustainable growth. Along the way, we continued to serve patients around the world, advance innovation across our portfolio, invest in our manufacturing network and enhance the capabilities that will shape our future. Most importantly, our people remained focused on what matters most: delivering life-saving and life-changing therapies, supporting public health, and making a meaningful difference for patients and donors worldwide. As we look ahead, our focus is clear. ✅Drive portfolio innovation and growth ✅Lead the industry in operational excellence ✅Enable and elevate our people Read our 2026 Annual Report: https://lnkd.in/gbrCqnHt #CSL #AnnualReport #Innovation #PatientsFirst
-
What does it take to help therapies safely reach patients around the world? For Rishi Chopra, it starts with keeping patients at the center of every decision. At CSL, he works across global Pharmacovigilance and Regulatory Affairs teams to help ensure therapies remain safe, effective and accessible for the people who need them most. Because advancing science also means advancing responsibility. Discover open R&D roles at CSL: https://lnkd.in/dbhEc33c #PeoplePoweringScience #CSLCareers #Innovation #Research #PatientSafety #RegulatoryAffairs #PromisingFutures #CSL
-
Living with a rare condition takes extraordinary courage. At CSL, we���re continuously inspired by the determination, perseverance and hope shown by patients and families around the world. Their journeys motivate us to keep pushing science forward. #CSL #RareDisease #Motivation
-
A wagging tail. A familiar face. A loyal friend. This International Dog Day, we’re celebrating the dogs who bring comfort, companionship and joy to patients every step of the way. #InternationalDogDay #CSL #PatientFocus
-
We welcomed more than 200 members of China's biotech community to our inaugural China Partnering Forum in Shanghai, bringing together entrepreneurs, investors and industry leaders to explore the future of healthcare innovation, in partnership with BFC Group Ltd. It was an opportunity for CSL leaders to share our scientific priorities, therapeutic area expertise and approach to external innovation, while engaging with innovators helping shape the future of biotechnology. Building on a four-decade partnership with China's healthcare community, we continue to engage with the country's vibrant biotech ecosystem. We are looking for the best science globally, and believe China's combination of world-class science, speed and efficiency, and strong partnership potential will help translate differentiated innovation into meaningful outcomes for patients worldwide. Hervé Gisserot, Michael Wilson, Stephen Pitt, Ph.D., Debbie Drane, Con Panousis, Jarrat Jordan, Sophie (Yu) Kuang. #Biotechnology #HealthcareInnovation #ExternalInnovation #Partnering #ChinaInnovation
-
-
At CSL, making a difference extends beyond the workday. Through our Workplace Giving Program, employees can support charitable organizations and causes that matter most to them, helping strengthen communities around the world. It’s one of the many ways our culture reflects the values we bring to work every day. Join a team committed to supporting communities and making a meaningful impact every day: https://lnkd.in/gdJy4DQv #CSLCareers #CSL
-
What inspires someone to dedicate their career to science? For Christopher, it started with something deeply personal. As a childhood leukemia survivor, he experienced firsthand how research can change lives. Today, he’s helping develop research models that give therapies the best possible chance to succeed. Because science isn’t just discovery; it’s impact. Explore how you can make an impact at CSL: https://lnkd.in/dbhEc33c #LifeAtCSL #PeoplePoweringScience #CSLCareers #CSL
-
Innovation doesn’t end when a therapy is approved. CSL’s continued commitment to the rare disease community reflects the work of teams focused on supporting patient access and delivering lasting impact. Teams across our organization work every day to help ensure innovations reach the people who need them. If you’re looking to build a career with lasting impact, you’ll find it at CSL. Explore careers: https://lnkd.in/gdJy4DQv #CSLCareers #CSL
-
Behind every plasma-derived therapy is an extraordinary act of generosity. It can take 1,200 plasma donations to treat one person with severe hemophilia for one year. Every donation represents hope for patients who rely on these therapies every day. #CSL #PlasmaDonation #PlasmaDerivedTherapies #Hemophilia